Literature DB >> 31686223

Diabetes in the Workplace: the Hazards of Hypoglycemia.

Robert M Gerbo1, Chuan Fang Jin2, Karen Clark3.   

Abstract

PURPOSE OF REVIEW: The effects of hypoglycemia can result in injury, including at work. Our goal was to review the recent medical literature regarding hypoglycemia and occupational injuries and provide guidance to clinicians asked to render opinions regarding fitness for work duties in individuals with diabetes. RECENT
FINDINGS: Recent studies contain conflicting conclusions regarding the occupational risks posed by workers with diabetes. However, the US Federal Motor Carrier Safety Administration concluded there was sufficient evidence to change the rule that previously disqualified commercial drivers with insulin-treated diabetes. Blanket employment policies that disqualify workers with diabetes are unnecessary in many occupational fields. In assessing occupational risks and fitness for duty in workers with diabetes, it is important to perform an individualized assessment of the worker and consider the risk factors for hypoglycemia, information from the treating clinician, essential functions of the job, and, if needed, availability of reasonable accommodations.

Entities:  

Keywords:  Diabetes; Hypoglycemia; Occupational hazards; Workplace accommodations

Mesh:

Year:  2019        PMID: 31686223     DOI: 10.1007/s11892-019-1234-2

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  22 in total

Review 1.  Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls.

Authors:  Ulrik Pedersen-Bjergaard; Birger Thorsteinsson
Journal:  Curr Diab Rep       Date:  2017-10-28       Impact factor: 4.810

2.  Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults.

Authors:  Arto Y Strandberg; Houssem Khanfir; Sari Mäkimattila; Tero Saukkonen; Timo E Strandberg; Fabian Hoti
Journal:  Ann Med       Date:  2017-02-10       Impact factor: 4.709

3.  What Conditions Should Be Assessed in Evaluating Individuals Who Work in Confined Spaces?

Authors:  Maria Carlota Borba Brum
Journal:  J Occup Environ Med       Date:  2016-04       Impact factor: 2.162

Review 4.  Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2016-11-21       Impact factor: 19.112

5.  FDA Approval of Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: A Potentially Risky Decision.

Authors:  Alan R Shapiro
Journal:  JAMA       Date:  2017-10-24       Impact factor: 56.272

Review 6.  9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

7.  Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.

Authors:  Antonios Douros; Hui Yin; Oriana Hoi Yun Yu; Kristian B Filion; Laurent Azoulay; Samy Suissa
Journal:  Diabetes Care       Date:  2017-09-01       Impact factor: 19.112

8.  Occupational injuries among workers with diabetes: the National Health Interview Survey, 1997-2005.

Authors:  Nancy L Sprince; Shirley Pospisil; Corinne Peek-Asa; Paul S Whitten; Craig Zwerling
Journal:  J Occup Environ Med       Date:  2008-07       Impact factor: 2.162

9.  Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study.

Authors:  Timothy M E Davis; David G Bruce; Judith Finn; Bradley H Curtis; Helen Barraclough; Wendy A Davis
Journal:  Diabetes Obes Metab       Date:  2018-11-25       Impact factor: 6.577

Review 10.  Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange.

Authors:  Gina Agiostratidou; Henry Anhalt; Dana Ball; Lawrence Blonde; Evgenia Gourgari; Karen N Harriman; Aaron J Kowalski; Paul Madden; Alicia H McAuliffe-Fogarty; Molly McElwee-Malloy; Anne Peters; Sripriya Raman; Kent Reifschneider; Karen Rubin; Stuart A Weinzimer
Journal:  Diabetes Care       Date:  2017-12       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.